{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:30:48Z","timestamp":1792654248177,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00108-018-0428-z","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T08:53:37Z","timestamp":1524732817000},"page":"551-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prim\u00e4r sklerosierende Cholangitis","Primary sclerosing cholangitis"],"prefix":"10.1007","volume":"59","author":[{"given":"T.","family":"Liwinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"428_CR1","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen TH, Folseraas T, Thorburn D et\u00a0al (2017) Primary sclerosing cholangitis \u2013 a\u00a0comprehensive review. J\u00a0Hepatol 67:1298\u20131323","journal-title":"J Hepatol"},{"key":"428_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/hep.26565","volume":"58","author":"K Boonstra","year":"2013","unstructured":"Boonstra K, Weersma RK, van Erpecum KJ et al (2013) Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 58:2045\u20132055","journal-title":"Hepatology"},{"key":"428_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus","year":"2005","unstructured":"Loftus EV, Harewood GC, Loftus CG et al (2005) PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91\u201396","journal-title":"Gut"},{"key":"428_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1055\/s-0043-120199","volume":"55","author":"CP Strassburg","year":"2017","unstructured":"Strassburg CP, Beckebaum S, Geier A et\u00a0al (2017) Sk2 Leitlinie Autoimmune Lebererkrankungen. Z\u00a0Gastroenterol 55:1135\u20131226","journal-title":"Z Gastroenterol"},{"key":"428_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000333","volume":"33","author":"WR Takakura","year":"2017","unstructured":"Takakura WR, Tabibian JH, Bowlus CL (2017) The evolution of natural history of primary sclerosing cholangitis. Curr Opin Gastroenterol 33:71\u201377","journal-title":"Curr Opin Gastroenterol"},{"key":"428_CR6","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","volume":"382","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield GM, Karlsen TH, Lindor KD et\u00a0al (2013) Primary sclerosing cholangitis. Lancet 382:1587\u20131599","journal-title":"Lancet"},{"key":"428_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","volume":"14","author":"X Jiang","year":"2017","unstructured":"Jiang X, Karlsen TH (2017) Genetics of primary sclerosing cholangitis and pathophysiological implications. Nat Rev Gastroenterol Hepatol 14:279\u2013295","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"428_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0037-1608801","volume":"37","author":"JR Hov","year":"2017","unstructured":"Hov JR, Karlsen TH (2017) The Microbiome in primary sclerosing cholangitis: current evidence and potential concepts. Semin Liver Dis 37:314\u2013331","journal-title":"Semin Liver Dis"},{"key":"428_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","volume":"102","author":"GG Kaplan","year":"2007","unstructured":"Kaplan GG, Laupland KB, Butzner D et al (2007) The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis. Am J Gastroenterol 102:1042\u20131049","journal-title":"Am J Gastroenterol"},{"key":"428_CR10","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ajg.2015.112","volume":"110","author":"KD Lindor","year":"2015","unstructured":"Lindor KD, Kowdley KV, Edwyn HM (2015) ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol 110:646\u2013659","journal-title":"Am J Gastroenterol"},{"key":"428_CR11","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.3748\/wjg.14.3781","volume":"14","author":"JR Hov","year":"2008","unstructured":"Hov JR, Boberg KM, Karlsen TH et\u00a0al (2008) Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 14:3781\u20133791","journal-title":"World J Gastroenterol"},{"key":"428_CR12","first-page":"e0164224","volume":"10","author":"H Ehlken","year":"2014","unstructured":"Ehlken H, Wroblewski R, Corpechot C et\u00a0al (2014) Validation of transient elastography and comparison with spleen length measurement for staging of fibrosis and clinical prognosis in primary sclerosing cholangitis. PLoS ONE 10:e164224","journal-title":"PLoS ONE"},{"key":"428_CR13","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.29293","volume":"66","author":"C Schramm","year":"2017","unstructured":"Schramm C, Eaton J, Ringe KI et al (2017) Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the international PSC study group. Hepatology 66:1675\u20131688","journal-title":"Hepatology"},{"key":"428_CR14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","volume":"98","author":"KW Burak","year":"2003","unstructured":"Burak KW, Angulo P, Lindor KD (2003) Is there a\u00a0role for liver biopsy in primary sclerosing cholangitis? Am J Gastroenterol 98:1155\u20131158","journal-title":"Am J Gastroenterol"},{"key":"428_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-2006-951599","volume":"26","author":"CP Strassburg","year":"2006","unstructured":"Strassburg CP, Manns MP (2006) Approaches to liver biopsy techniques \u2013 revisited. Semin Liver Dis 26:318\u2013327","journal-title":"Semin Liver Dis"},{"key":"428_CR16","doi-asserted-by":"publisher","first-page":"CD003626","DOI":"10.1002\/14651858.CD003626.pub2","volume":"19","author":"G Poropat","year":"2011","unstructured":"Poropat G, Giljaca V, Stimac D et\u00a0al (2011) Bile acids for primary sclerosing cholangitis. Cochrane Database Syst Rev 19:CD3626. https:\/\/doi.org\/10.1002\/14651858.CD003626.pub2","journal-title":"Cochrane Database Syst. Rev."},{"key":"428_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2036.2011.04822.x","volume":"34","author":"CK Triantos","year":"2011","unstructured":"Triantos CK, Koukias NM, Nikolopoulou VN et al (2011) Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis. Aliment Pharmacol Ther 34:901\u2013910","journal-title":"Aliment Pharmacol Ther"},{"key":"428_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/liv.12640","volume":"35","author":"E Seth Von","year":"2015","unstructured":"Von Seth E, Arnelo U, Enochsson L et\u00a0al (2015) Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography. Liver Int 35:254\u2013262","journal-title":"Liver Int"},{"key":"428_CR19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/s-0043-107029","volume":"49","author":"L Aabakken","year":"2017","unstructured":"Aabakken L, Karlsen TH, Albert J et\u00a0al (2017) Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy 49:588\u2013608","journal-title":"Endoscopy"},{"key":"428_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","volume":"96","author":"M Kaya","year":"2001","unstructured":"Kaya M, Petersen BT, Angulo P et\u00a0al (2001) Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis. Am J Gastroenterol 96:1059\u20131066","journal-title":"Am J Gastroenterol"},{"key":"428_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.gie.2010.02.043","volume":"72","author":"AA Negm","year":"2010","unstructured":"Negm AA, Schott A, Vonberg RP et\u00a0al (2010) Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 72:284\u2013291","journal-title":"Gastrointest Endosc"},{"key":"428_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1080\/003655202760373434","volume":"37","author":"KM Boberg","year":"2002","unstructured":"Boberg KM, Bergquist A, Mitchell S et\u00a0al (2002) Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol 37:1205\u20131211","journal-title":"Scand J Gastroenterol"},{"key":"428_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MOG.0000000000000335","volume":"33","author":"H Ehlken","year":"2017","unstructured":"Ehlken H, Zenouzi R, Schramm C (2017) Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance. Curr Opin Gastroenterol 33:78\u201384","journal-title":"Curr Opin Gastroenterol"},{"key":"428_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ajg.2011.361","volume":"107","author":"JE Eaton","year":"2012","unstructured":"Eaton JE, Thackeray EW, Lindor KD (2012) Likelihood of malignancy in gallbladder polyps and outcomes following cholecystectomy in primary sclerosing cholangitis. Am J Gastroenterol 107:431\u2013439","journal-title":"Am J Gastroenterol"},{"key":"428_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29730","author":"AH Ali","year":"2017","unstructured":"Ali AH, Tabibian J, Nasser-Ghodsi N (2017) Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis. Hepatology. https:\/\/doi.org\/10.1002\/hep.29730","journal-title":"Hepatology"},{"key":"428_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1053\/j.gastro.2010.10.014","volume":"140","author":"P Angulo","year":"2011","unstructured":"Angulo P, Grandison GA, Fong DG et\u00a0al (2011) Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 140:180\u2013188","journal-title":"Gastroenterology"},{"key":"428_CR27","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/hep.26909","volume":"60","author":"U Beuers","year":"2014","unstructured":"Beuers U, Kremer AE, Bolier R (2014) Pruritus in cholestasis: facts and fiction. Hepatology 60:399\u2013407","journal-title":"Hepatology"},{"key":"428_CR28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gut.2010.228924","volume":"60","author":"BE Wellge","year":"2011","unstructured":"Wellge BE, Sterneck M, Teufel A et\u00a0al (2011) Pregnancy in primary sclerosing cholangitis. Gut 60:1117\u20131121","journal-title":"Gut"},{"key":"428_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cgh.2013.07.011","volume":"12","author":"JF Ludvigsson","year":"2014","unstructured":"Ludvigsson JF, Bergquist A, Ajne G et al (2014) A population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 12:95\u2013100","journal-title":"Clin Gastroenterol Hepatol"},{"key":"428_CR30","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1111\/j.1572-0241.1999.01543.x","volume":"94","author":"P Angulo","year":"1999","unstructured":"Angulo P, Larson DR, Therneau TM et\u00a0al (1999) Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 94:3310\u20133313","journal-title":"Am J Gastroenterol"},{"key":"428_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/lt.24350","volume":"22","author":"T Hildebrand","year":"2016","unstructured":"Hildebrand T, Pannicke N, Dechene A, German PSC Study Group (2016) Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis \u2013 a\u00a0retrospective multicenter analysis. Liver Transpl 22:42\u201352","journal-title":"Liver Transpl"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-018-0428-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-018-0428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T08:54:08Z","timestamp":1604220848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-018-0428-z"}},"subtitle":["Aktuelle Diagnostik und Therapie","Current diagnostics and treatment"],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1007\/s00108-018-0428-z","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"26 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Liwinski und C.\u00a0Schramm geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}